See What HealthDay Can Do For You
Contact Us

Lower Live Birth Rate With Minimal Stimulation IVF

Women undergoing mini-IVF have no ovarian hyperstimulation, reduced multiple pregnancy rates


THURSDAY, Jan. 14, 2016 (HealthDay News) -- Minimal stimulation in vitro fertilization (mini-IVF) is associated with reduced live birth rates compared with conventional IVF, according to a study published in the January issue of the American Journal of Obstetrics & Gynecology.

John J. Zhang, M.D., Ph.D., from the New Hope Fertility Center in New York City, and colleagues performed a randomized noninferiority controlled trial, with a prespecified 10 percent border, comparing one cycle of mini-IVF with single embryo transfer with one cycle of conventional IVF with double embryo transfer. A total of 564 couples (women aged <39 years) who were undergoing their first IVF cycle were randomized to mini-IVF (285 couples) or conventional IVF (279 couples).

The researchers found that the cumulative live birth rates were 49 and 63 percent for mini-IVF and conventional IVF, respectively (relative risk, 0.76). Ovarian hyperstimulation syndrome did not occur after mini-IVF, compared with 5.7 percent of cases after conventional IVF. The multiple pregnancy rates were 6.4 and 32 percent, respectively, in mini-IVF and conventional IVF (relative risk, 0.25). Compared with conventional IVF, gonadotropin use was significantly lower with mini-IVF (P < 0.0001).

"How these different dimensions are weighed by couples who are deciding between mini-IVF or conventional IVF and whether the lower live birth rate could be offset by a series of 'lower cost' mini-IVF cycles should be the subject of future studies," the authors write.

Full Text (subscription or payment may be required)

Physician's Briefing


HealthDay is the world’s largest syndicator of health news and content, and providers of custom health/medical content.

Consumer Health News

A health news feed, reviewing the latest and most topical health stories.

Professional News

A news feed for Health Care Professionals (HCPs), reviewing latest medical research and approvals.